Rezpegaldesleukin
nektar therapeutics,eli lilly
['derm', 'aldesleukin', 'psoriasis', 'atopic dermatitis ', 'nektar']
$nktr nektar therapeutics presents data for rezpegaldesleukin (ly3471851) in patients with atopic dermatitis and psoriasis from two separate clinical studies at 2022 european academy of dermatology (eadv) congress 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6